Tweet
Lead Article:
AstraZeneca COVID Vaccine: Clotting Disorder Mechanism Revealed?
The European Medicines Agency (EMA) continues to reassure the public about the safety of the AstraZeneca COVID-19 vaccine, although several countries have imposed new restrictions on the product, owing to its link to a rare clotting disorder.
Use of the vaccine has been suspended for individuals younger than 55 or 60 years in several European countries and in Canada after reports of a prothrombotic disorder and thrombocytopenia, mainly in younger individuals.
Use of the vaccine has been suspended for individuals younger than 55 or 60 years in several European countries and in Canada after reports of a prothrombotic disorder and thrombocytopenia, mainly in younger individuals.
COVID Vaccines Could Lose Their Punch Within a Year, Experts Say.
COVID Antibodies May Last Days to Years, Depending on Severity of Infection
There is a lot of "may" and "could" in these articles. Certainly a lot we don't know long term.
Kyle
Comment